Vietnamese Journal of Neurology

Article detail

Article detail description

Home
Articles Issue: Số 32 - 2022 Viêm tủy

Assessment clinical, laboratory characteristics and some related factors of recurrent in patient with transverse myelitis

Published: March 18, 2022
Lượt đọc: 0

Abstract

Objectives: Transverse myelitis is an acute or subacute disease of the spinal cord which causes the abnormalities in the motor, sensory and autonomic function of the spinal cord. This is a rare disease with many different causes. In Vietnam, we haven’t seen many research on that disease yet, especially there was a little data on the recurrence as well as preventive treatment of that disease. As the result, our goal of the research is to firstly describe the clinical and laboratory characteristics, some prognosis factors of patients with transverse myelitis. Methods: Retrospective descriptive study of 25 patients in Neurology Department of 108 Military Hospital from January, 2014 to May, 2019. Results: The average age of patients was 44.8 ± 13.4 years old with the percentage of women was 52% and the duration of the plateau phase of symptoms under 2 weeks was 60%. The percentage of the lesion in the thoracic spinal cord was 61.9%, the lesion which was up to the medullary was 14.3% and the lesion which was longer than 2 vertebral segments was 90.5%. The changes in the cerebrospinal fluid (CSF) was seen in 88% of patients with 44% increase in the number of blood cells, 56% increase in the protein level and 68% with positive Pandy’s reaction. In the following-up time of average 34 months, there was 59% of recurrence. Patients with these factors including elevated CSF protein level, the lesion longer than 2 vertebral segments were at higher risk of recurrence. Patients with recurrence had worse functional status (mRs 3.0 ± 1,9 vs 1.67 ± 1.0, p < 0,01). Conclusion: Patients with the lesion longer than 2 vertebral segments and elevated CSF protein level were at higher risk of recurrence. Patients with recurrence had worse functional status.

Keywords
transverse myelitis recurrence

References

1.
Maillart, E., et al., Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies. Journal of Neuroinflammation, 2020. 17(1): p. 128.
2.
Zalewski, N.L., E.P. Flanagan, and B.M. Keegan, Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses. Neurology, 2018. 90(2): p. e96.
3.
Kitley J, et al, Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies. JAMA Neurology, 2013. 70(11): p. 1375-1381.
4.
S. Presas-Rodríguez, L.G.-L., J.V. Hervás-Garcíaa, A. Massuet-Vilamajó, C. Ramo-Telloa, Myelitis: Differences between multiple sclerosis and other aetiologies. Neurología, 2016. 31: p. 71—75.
5.
Aijaz Ali, S.B.B., Amir Riaz, at al, Assessment of Clinical Outcomes in Patients Presenting with Transverse Myelitis: A Tertiary Care Experience from a Developing Country. Cureus e4342, 2019. 11(3): p. e4342.
6.
Sato, D.K., et al., Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. 2014. 82(6): p. 474-481.
7.
Dubey, D., et al., Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA neurology, 2019. 76(3): p. 301-309.
8.
Barnes, G., et al., Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology, 2002. 59: p. 499-505.
9.
Kimbrough, D.J., et al., Predictors of recurrence following an initial episode of transverse myelitis. Neurol Neuroimmunol Neuroinflammation, 2014. 1(1): p. e4.
10.
Alvarenga, M.P., et al., The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro. Journal of Neurology, 2010. 257(6): p. 992-998.
11.
Gajofatto, A., et al., Assessment of Outcome Predictors in First-Episode Acute Myelitis: A Retrospective Study of 53 Cases. Archives of Neurology, 2010. 67(6): p. 724-730.
12.
Tobin, W.O., B.G. Weinshenker, et al, Longitudinally extensive transverse myelitis. Current opinion in neurology, 2014. 27(3): p. 279-289.
13.
Apostolos-Pereira, S., et al., Differential Diagnosis of Longitudinally Extensive Transverse Myelitis (P02.109). 2013. 80(7 Supplement): p. P02.109-P02.109.
14.
Abdullah, S., W.F. Wong, and C. Tan, The Prevalence of Anti-Aquaporin 4 Antibody in Patients with Idiopathic Inflammatory Demyelinating Diseases Presented to a Tertiary Hospital in Malaysia: Presentation and Prognosis. Multiple Sclerosis International, 2017. 2017: p. 1-6.
15.
Bulut, E., et al., MRI Predictors of Recurrence and Outcome after Acute Transverse Myelitis of Unidentified Etiology. 2019. 40(8): p. 1427-1432.

Authors

Nguyễn Hồng Quân Bệnh viện Trung ương Quân đội 108 Nguyễn Cao Vinh Bệnh viện Trung ương Quân đội 108 Phạm Cẩm Diệu Linh Bệnh viện Trung ương Quân đội 108 Nguyễn Tường Ngọc Linh Bệnh viện Trung ương Quân đội 108 Trần Thị Thúy Hằng Bệnh viện Trung ương Quân đội 108
Assessment clinical, laboratory characteristics and some related factors of recurrent in patient with transverse myelitis

Files

Trích dẫn

APA

Định dạng

Article Views0
Document Views0
Downloads0
Section Articles
Category Viêm tủy
Pages 28-33
Copyright Holder 2022 Vietnamese Journal of Neurology